<DOC>
	<DOCNO>NCT00336596</DOCNO>
	<brief_summary>The purpose present , randomize , control multicenter phase III trial investigate safety efficacy continuous 1-hour insonation occlude middle cerebral artery 2 MHz TCCS stroke patient treat intravenous tissue plasminogen activator ( t-PA ) within 3 hour symptom onset .</brief_summary>
	<brief_title>Ultrasound Enhanced Thrombolytic Therapy Middle Cerebral Artery Occlusion</brief_title>
	<detailed_description>Thrombolysis intravenous ( iv ) tissue plasminogen activator ( t-PA ) effective approve therapy acute ischemic stroke . The frequent cause ischemic stroke thrombosis middle cerebral artery ( MCA ) . Preliminary vitro , animal human study suggest ultrasound accelerates thrombolysis induce t-PA , recanalization acute MCA occlusion due thrombolysis independent predictor good clinical outcome . Thus , insonation occlude MCA temporal bone stroke patient treated iv t-PA might enhance recanalization improve clinical outcome . The present prospective , randomize , control multicenter pilot study investigate safety efficacy continuous 1-hour insonation occlude MCA 2 MHz transcranial color duplex sonography patient ischemic stroke treat iv t-PA within 3 hour symptom onset . It plan randomize 400 patient 6 Swiss center enrolment period 33 month individual follow 3 month . The study endpoint include safety efficacy assessment . The primary safety endpoint determine rate symptomatic intracranial hemorrhage ( ICH ) treatment group . The primary efficacy endpoint determine whether good functional outcome ( modify Rankin scale , mRs , score 0-2 ) differs treatment group . Secondary endpoint include ( 1 ) asymptomatic ICH occur within first 24-48 hour t-PA infusion , ( 2 ) early clinical recovery 10 National Institute Health Stroke Scale ( NIHSS ) point dramatic recovery ( total NIHSS score 3 less ) 24-48 hour t-PA infusion , ( 3 ) mean mRS score 90 day t-PA infusion , ( 4 ) death occur study period , ( 5 ) recanalization 24-48 hour t-PA infusion .</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Intracranial Embolism</mesh_term>
	<mesh_term>Infarction , Middle Cerebral Artery</mesh_term>
	<mesh_term>Fibrinolytic Agents</mesh_term>
	<criteria>acute ischemic stroke MCA territory accord clinical cranial compute tomography ( CT ) cranial MR imaging ( MRI ) find patient undergo iv thrombolysis tPA within 3 hour stroke onset Occlusion sphenoidal ( M1 ) insular ( M2 ) segment MCA CT ( CTA ) , MR ( MRA ) catheter ( CA ) angiography appropriate temporal bony window without echocontrast agent insonation TCCS full functional independence prior present stroke ( mRS 01 ) , use cane walking due comorbid condition acceptable write informed consent , sign date subject ( subject 's authorized representative , allow local law ) person obtain consent , indicate agreement comply protocolspecific procedure unconsciousness ( 2 point item 1a NIHSS ) history intracranial hemorrhage , arteriovenous malformation aneurysm severe craniocerebral trauma within last 3 month symptom subarachnoidal hemorrhage time symptom onset unclear large surgical intervention trauma within last 10 day expect survival 90 day iv tPA treatment severe hepatic disease , esophageal varix , acute pancreatitis septic embolism , endocarditis , pericarditis myocardial infarction pregnancy childbirth within last 30 day nurse mother history hemorrhagic diathesis coagulopathy untreatable increase arterial blood pressure ( &gt; 185mmHg systolic , &gt; 110mmHg diastolic ) intracranial hemorrhage , arteriovenous malformation aneurysm brain imaging thrombocyte &lt; 100'000 per microliter international normalize ratio ( INR ) &gt; 1.7 partial thromboplastin time ( PTT ) prolongated serum glucose &lt; 2.7mmol/l &gt; 22.2mmol/l severe renal insufficiency contraindication CTcontrast agent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>middle cerebral artery occlusion</keyword>
	<keyword>intracranial embolism thrombosis</keyword>
	<keyword>ultrasound enhance thrombolysis</keyword>
	<keyword>Patients receive iv thrombolytic therapy ( t-PA )</keyword>
</DOC>